U.S. Leisure Stock News

Healthpeak Properties (DOC) is back in focus after its board affirmed a monthly common stock cash dividend of $0.10167 per share for the second quarter of 2026, which is annualized at $1.22. See our latest analysis for Healthpeak Properties. At a share price of US$16.74, Healthpeak Properties has recently shown modest near term momentum, with a 7 day share price return of 1.33%. However, its 1 year total shareholder return of a 1.18% decline and 5 year total shareholder return of a 33.99%...

Why Universal Technical Institute (UTI) is back on investors’ radar Universal Technical Institute (UTI) recently posted a quarter where revenue and earnings came in ahead of forecasts, and also unveiled plans for several new campuses that will extend its transportation, skilled trades, and healthcare footprint. See our latest analysis for Universal Technical Institute. That growth story is showing up in the share price too, with the stock at $35.58 after a 29.38% 90 day share price return and...

Earlier this month, New Jersey Resources reported fiscal 2026 first-quarter results that beat Wall Street expectations for both earnings per share and revenue, reflecting stronger performance across its utility and energy-related segments. The upside surprise in earnings has reinforced investor attention on how the company’s mix of natural gas distribution and clean energy initiatives is contributing to its current financial performance. Next, we’ll assess how this earnings beat and renewed...

Domino's Pizza Inc. recently launched Slice Sauce, its first dedicated pizza dipping sauce, and ran a promotion giving customers a free Slice Sauce with any online Handmade Pan or Parmesan Stuffed Crust Pizza purchase through June 14, while also providing password-only access to a curated Shinola collection featuring black-and-gold watches and leather goods at preferred rates. This collaboration links Domino's core menu innovation with a premium lifestyle brand, signaling an effort to...

Why Everus Construction Group (ECG) is on investors’ radar Everus Construction Group (ECG) has drawn fresh attention after a period of strong recent share performance, with the stock showing positive returns over the past week, month, past 3 months and year. For investors watching capital goods names, the company’s US focused contracting business, spanning Electrical & Mechanical and Transmission & Distribution services, offers a mix of infrastructure exposure and earnings tied to utilities,...

In recent days, Opendoor Technologies has been in focus as fresh economic and housing data pointed to weaker consumer conditions, slowing growth, rising inflation, and the sharpest drop in U.S. pending home sales in three months, while mortgage rates climbed to their highest level since September. These macro pressures, combined with concerns about Opendoor’s inventory-heavy, interest-rate‑sensitive model and mixed options and retail sentiment signals, have intensified questions about the...

In early April 2026, Markel Group Inc. disclosed that its upcoming May 20, 2026 annual meeting would consider amendments to its Articles of Incorporation alongside shareholder proposals seeking the right for 10% owners to call special meetings and a report on plans to mitigate material environmental risks. The company’s decision to recommend voting against both the special-meeting and environmental-risk reporting proposals highlights a clear tension between management’s preferred governance...

In March 2026, Astrana Health, Inc. filed shelf registrations, including an ESOP-related shelf of up to US$120.95 million for 5,000,000 common shares, alongside a broad universal shelf covering common and preferred stock, debt securities, depositary shares, warrants, purchase contracts, units, and subscription rights. This broad financing toolkit, including employee stock ownership plan capacity and multiple capital instruments, gives Astrana additional flexibility to support future...

Fox (FOXA) is in focus after announcing an integration with prediction market Kalshi. The deal will bring real-time, crowd-sourced odds into FOX News, FOX Business Network, FOX Weather, and FOX One programming. See our latest analysis for Fox. Despite an initial jump on the Kalshi news, the 1-day share price return of 2.77% decline sits against a 7-day share price return of 4.09% and a 90-day share price return of 17.18% decline. Total shareholder returns of 26% over 1 year and 89.69% over 3...

Why Rollins (ROL) is back in focus after its latest quarterly update Rollins (ROL) has moved back onto investors’ watchlists after reporting quarterly results where revenue was higher year on year, but adjusted operating income fell short of market expectations. See our latest analysis for Rollins. The earnings miss appears to have weighed on sentiment, with a 1 day share price return showing a 2.8% decline at US$54.23 and a 90 day share price return showing a 10.63% decline. However, the 5...

Vertical Aerospace announced in March 2026 that it had reached an agreement in principle for up to US$775,000,000 in new financing, including senior secured convertible notes, Series A convertible preferred shares and an equity line of credit with Mudrick Capital Management and Yorkville Advisors. This combination of sizeable, structured funding and the recent first piloted transition flight of its full-scale eVTOL aircraft under U.K. CAA oversight marks a meaningful step in aligning...

MINISO Group Holding (MNSO) has released a packed update, combining fourth quarter and full year 2025 earnings with fresh dividend details and progress on its multi quarter share buyback program. See our latest analysis for MINISO Group Holding. Despite the fresh dividend announcements and the update on its multi quarter buyback, MINISO Group Holding's 1 day share price return of 3.06% decline and 90 day share price return of 20.10% decline contrast with a 1 year total shareholder return of...

In recent days, attention on Waste Management has intensified ahead of its April 28, 2026 earnings release, as analysts highlight expectations for higher quarterly and full‑year profit and revenue alongside the company’s ongoing share repurchase program and decades-long pattern of dividend increases. This combination of anticipated profit growth, sustained capital returns, and growing interest in recycling and renewable natural gas has become a key focus for investors reassessing Waste...

Vertiv Holdings Co recently committed about US$50 million to expand its Ironton manufacturing plant and Westerville headquarters in Ohio, aiming to boost liquid cooling and chilled water system capacity for AI and high-density computing while adding hundreds of jobs through 2029. This expansion underpins Vertiv’s broader role as a critical provider of power and thermal infrastructure for AI data centers, reinforcing its ability to meet rising demand with shorter supply chains and greater...

In early April 2026, Anthropic, Genentech, IBM, Meta, Microsoft, and others launched the Shared AI License Foundation and IBM expanded its AI, quantum, and hardware collaborations, while also securing FedRAMP authorization for 11 watsonx and automation tools and settling a US$17,000,000 U.S. DEI probe. Together, these moves underline IBM’s push to position itself at the center of open, enterprise-grade AI and quantum infrastructure while addressing regulatory scrutiny. We’ll now explore how...

Array Technologies, Inc. recently disclosed that seven independent directors, including long-serving members and newer renewable-energy specialists, will not stand for re-election at the May 19, 2026 annual meeting, while also proposing to phase out its classified board structure in favor of annual director elections by 2029. This combination of significant board turnover and a move toward annual elections signals a shift in corporate governance that may recalibrate how investors assess...

On 9 April 2026, Amneal Pharmaceuticals announced it had launched bimatoprost ophthalmic solution 0.01% in multiple vial sizes, a generic equivalent to Allergan’s LUMIGAN indicated for reducing elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension. This launch adds a high-usage ophthalmic therapy with approximately US$719 million in recent U.S. annual sales to Amneal’s generics portfolio, underlining its focus on expanding access to lower-cost treatments...

In early April 2026, Mohawk Industries filed a definitive proxy statement urging shareholders to vote against John Chevedden’s proposal to replace supermajority voting thresholds with a simple majority standard in its charter and bylaws. This clash over corporate governance comes as Mohawk is already in the spotlight for mixed quarterly results, efficiency initiatives, and active capital returns. We’ll now examine how this governance dispute, alongside Mohawk’s recent restructuring...

The Federal Energy Regulatory Commission’s decision to lower allowed returns for New England transmission owners is set to trim Eversource Energy (ES) 2026 after-tax earnings, prompting updated guidance and raising fresh questions for income-focused investors. See our latest analysis for Eversource Energy. At a share price of US$69.97, Eversource’s recent 5.4% 1 month share price decline contrasts with a 3.2% 3 month share price gain and a 30.0% 1 year total shareholder return. This suggests...

Cohen & Steers recently reported preliminary assets under management of US$93.10 billion as of March 31 2026, down from US$98.40 billion a month earlier, with the decline mainly linked to market depreciation and client distributions, partly offset by net inflows. This shift in assets under management highlights how market conditions and payout decisions can affect fee-earning assets even when new client money is coming in. We’ll now explore how this recent assets-under-management decline may...

In recent weeks, Brigade Group subsidiaries BCV Developers and Brigade Hotel Ventures announced new management agreements with Hyatt for Hyatt House Bengaluru Devanahalli, slated to open in 2027, and Grand Hyatt Chennai ECR, targeted for 2029, while Hyatt Regency Niagara Falls Fallsview joined the World of Hyatt portfolio and Caption by Hyatt Chattanooga Downtown opened as the brand’s first property in the city. Taken together, these openings and signings highlight Hyatt’s push into...

Roivant Sciences recently reported that Priovant has begun enrolling patients in a seamless Phase 2b/3 trial of brepocitinib for lichen planopilaris and released past topline Phase 3 data from Immunovant’s batoclimab thyroid eye disease studies, which did not meet their primary endpoint but showed consistent safety. The update underscores Roivant’s growing late-stage immunology pipeline, led by brepocitinib’s FDA Priority Review in dermatomyositis and multiple additional indications...

In late March and early April 2026, UroGen Pharma announced publication of pivotal Phase 3 ENVISION data for bladder cancer therapy ZUSDURI and launched its “LG-UTUC Luminaries” program to recognize leaders in kidney-sparing care for rare upper tract urothelial cancer. Together, these steps highlight UroGen’s push to embed ZUSDURI’s evidence into clinical practice while deepening relationships with urologists focused on organ-preserving cancer management. Next, we’ll examine how the ENVISION...

Why Babcock & Wilcox Enterprises (BW) is in Focus Today Pomerantz LLP has opened an investigation into Babcock & Wilcox Enterprises (BW) for possible securities law violations, following a Wolfpack Research report on alleged conflicts tied to a $2.4b power generation contract. The short seller claims and legal scrutiny have drawn fresh attention to BW, prompting investors to reassess the company’s governance, risk profile, and how the stock’s recent moves compare with its underlying...